Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Charles Schwab Investment Management Inc. raised its position in DXC Technology (NYSE:DXC – Free Report) by 3.5% in the 4th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback